-
Jun 3, 2019, 5:54 pm183 pts
MJBizDaily
A federal appeals court in New York told the U.S. Drug Enforcement Administration (DEA) to “promptly” reconsider its classification of cannabis as a Schedule 1 drug. While it’s unclear whether the DEA will act, such a move could have a wide-ranging impact on medical cannabis businesses and research. “I…
Trending Today on NewsBudz
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
